IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
82 hedge funds and large institutions have $305M invested in IGM Biosciences in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 36 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
-10
Holders Change %
-10.87%
% of All Funds
1.32%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
36
Reduced
23
Closed
15
Calls
$1.07M
Puts
$165K
Net Calls
+$903K
Net Calls Change
+$37K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$11.8M |
| 2 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$2.7M |
| 3 |
Renaissance Technologies
New York
|
$1.58M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$9.82M |
| 5 |
D.E. Shaw & Co
New York
|
$6.63M |
